Artwork

Indhold leveret af The New York Academy of Sciences. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The New York Academy of Sciences eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Reevaluating Clinical Trial Design

49:02
 
Del
 

Manage episode 189900630 series 1455219
Indhold leveret af The New York Academy of Sciences. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The New York Academy of Sciences eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Clinical trials to evaluate new drugs are typically built around one design, the randomized controlled trial, but this method has come under scrutiny in recent years for being expensive, lengthy, and cumbersome. In this podcast you'll hear from experts asking if alternative designs would be better for determining the safety and efficacy of new therapies. This podcast was produced following a conference on this topic held in partnership between the NYU School of Medicine and the Academy. It was made possible with support from Johnson and Johnson.
  continue reading

256 episoder

Artwork
iconDel
 
Manage episode 189900630 series 1455219
Indhold leveret af The New York Academy of Sciences. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The New York Academy of Sciences eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Clinical trials to evaluate new drugs are typically built around one design, the randomized controlled trial, but this method has come under scrutiny in recent years for being expensive, lengthy, and cumbersome. In this podcast you'll hear from experts asking if alternative designs would be better for determining the safety and efficacy of new therapies. This podcast was produced following a conference on this topic held in partnership between the NYU School of Medicine and the Academy. It was made possible with support from Johnson and Johnson.
  continue reading

256 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning

Lyt til dette show, mens du udforsker
Afspil